TARO - Taro Pharmaceutical GAAP EPS of $0.73 revenue of $143.26M May, 27 2022 02:10 AM Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical press release (NYSE:TARO): Q4 GAAP EPS of $0.73. Revenue of $143.26M (-3.4% Y/Y). For further details see: Taro Pharmaceutical GAAP EPS of $0.73, revenue of $143.26M